Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion type Assertion NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_head.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion description "[PEG-IFN-alfa 2b 1.5 microg/kg/wk was superior to IFN-alfa 2b in decreasing mean serum hepatitis C RNA ( P < .05 at week 12).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_provenance.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion evidence source_evidence_literature NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_provenance.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion SIO_000772 15952104 NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_provenance.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion wasDerivedFrom befree-2016 NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_provenance.
- NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_assertion wasGeneratedBy ECO_0000203 NP499169.RAAp5objdMNdzaGHBh4_vj2Ab8DybP7AsdmlKL2cWJNtM130_provenance.